Bufexamac-containing products for topical use
updated: 2010.05.05
A two-year period for selling bufexamac-contianing products cannot be granted according to BfArM’s Feststellungsbescheid (ascertainment decision). Prior to the BfArM order the authorisation holders had abandoned their marketing authorisations in Germany.
risk information - full text (available in German only)